S5W-25799-74915
2 vaccinations
1 coded response
23 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 871 / NM
- Registered
- 2021-01-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-23
Dose 1 — Pfizer-BioNTech
-
2021-01-24
Registered in v-safe
-
2021-01-24
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-25
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-01-26
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-02-06
-
2021-02-12
Dose 2 — Pfizer-BioNTech
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-14
-
2021-02-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-16
- 2021-02-17
-
2021-02-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-19
Health check-in — day 7, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-21
- 2021-03-26
- 2021-05-14
-
2021-08-13
Survey response — 6 months, dose 2MedDRA: Uterine dilation and curettage, Uterine leiomyoma — Feeling: Good · Get care from a doctor or other healthcare professional · HospitalizationFree text: I had a D and C for an abnormal growth in uterus.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-13
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-18
- 2022-02-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-23 | Pfizer-BioNTech | |
| 2 | 2021-02-12 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-08-13 | Unsuccessful |
Free text
Release 9 — 6 months, dose 2
Symptoms: I had a D and C for an abnormal growth in uterus.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Uterine dilation and curettage | ✓ | · | ✓ |
| SD | Uterine leiomyoma | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release